Cardiogram Signs Deal with Oscar Health to Allow Members Free Wearable-Based Monitoring

Cardiogram Oscar Health Deal

Cardiogram, a digital health startup that makes smartwatch app to detect health conditions like diabetes and atrial fibrillation (Afib), has cut a deal with upstart insurer Oscar Health. The deal makes Oscar Health members eligible for Cardiogram’s wearable-based monitoring for atrial fibrillation and diabetes, without paying out-of-pocket.

Related Cardiogram Joins Garmin to Integrate its Heart Health App into Garmin Wearables

“You will be monitored for signs of diabetes and atrial fibrillation, and if it turns out you are at a high risk for one of these conditions you will be offered a confirmatory test, so a blood test or an ECG,” Brandon Ballinger, cofounder of Cardiogram, told MobiHealthNews. “And if that confirms you have that condition, then you will be referred to an in network for physician for Oscar.”

The new partnership comes after a 2018 study, done in collaboration with UC San Francisco, showed Cardiogram can detect diabetes in patients with 85 percent accuracy.

In order to take advantage of the benefit, an Oscar member would need to have their own Apple Watch, Garmin or Android wearable which can be linked to the Cardiogram app for passive health monitoring.

If Cardiogram’s technology highlights a potential issue of Afib or diabetes, patients will be given free access to what the company calls a “gold standard” diagnostic test to confirm the results.

“So it is not just an algorithm or technology — it is a full clinical workflow that guides Oscar members to treatment and better health,” Ballinger said.

cardiogram app

The program is designed not only for people with health conditions, but also for healthy people. The technology lets users monitor their resting heart rate, sleep and stress, according to Ballinger. Additionally, a feature added in January allows, members already managing a health condition to share their data with a doctor.

“For chronic conditions like diabetes, atrial fibrillation, hypertension, and sleep apnea, anywhere between 20–80% of cases are undiagnosed. These are people with serious, worsening medical conditions who are at a dramatically higher risk of acute complications, yet are not receiving appropriate care,” said Cardiogram in its blog.

Related Wearable Tech Can Safely Detect Atrial Fibrillation, Says Apple Heart Study

WT | Wearable Technologies Conference in San Francisco on July 9-10

The most innovative wearables event will be back on July 9-10 in beautiful San Francisco at SEMICON West to celebrate the 34th edition of the WT | Wearable Technologies Conference Series. Topics include data analytics in professional sports, prevention, treatment and rehabilitation with wearables, the future of digital health, medication and adherence, smart patches, workflow optimization and workforce safety and much more – featuring international leaders and experts of the wearables industry´s biggest names including Abbott, Datwyler, Kopin, Maxim Integrated, Multek, NFLPA, Omron, SharkDreams, Qualcomm, Viewpointsystem and many more. Register now to be part of #WTUS19

Previous articleSKIIOT: The Next Generation Skiing Analyzer
Next articleFlytta Smartwatch: A New Approach to Parkinson’s Care
Cathy Russey
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)